GUIDELINES ON VALIDATION APPENDIX 4 ANALYTICAL …
The tests to be performed 136 should be described in the documentation on standard test methods. 137 2.2 138 Specifications and standard test methods in pharmacopoeias (“pharmacopoeial 139 methods”), or suitably developed specifications or test methods (“non-pharmacopoeial methods”)
Download GUIDELINES ON VALIDATION APPENDIX 4 ANALYTICAL …
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
1. Name of pharmacopoeia - WHO
www.who.int9. Publication of harmonized pharmacopoeial texts within the pharmacopoeia If yes, which pharmacopoeia: JP & USP If yes, which type: individual monograph on excipients and general chapters If yes, how many: – 28 of the 35 General Chapters and 41 of the 61 excipient monographs of the current work programme have been harmonised.
Q4B Annex 14 Step 3 Bacterial Endotoxins
www.ema.europa.euPharmacopoeial Texts for Use in the ICH Regions on Bacterial Endotoxins Tests – General Chapter . Step 3 . Transmission to CHMP . September 2010. Adoption by CHMP for release for consultation September 2010; End of consultation (deadline for comments) December 2010: Comments should be provided using this .
Guideline on Summary of requirements for active …
www.ema.europa.eutests in relation to reference substances sufficiently described in the dossier. In the case of pharmacopoeial active substances: • Stability data may not be necessary where adequate literature evidence can be cited and summarised and where the monograph covers the degradation products for which suitable